Legato Merger IV

A $200 million blank check from the Legato franchise with a 25% promote and an effective 27-month runway if a deal is signed by month 24; the 15% redemption cap is the notable restriction for arbitrage holders.

This filing confirms the mechanics of the proposed IPO and the post-IPO redemption calendar. The trust will hold $10.00 per unit (or $10.00 before interest), and the deadline for a business combination is 24 months from IPO closing (or 27 months if an LOI or definitive agreement is signed within 24 months), after which the trust is liquidated. Initial shareholders paid $25,000 for founder shares and will purchase private units. The filing also details the 15% redemption limit for public shareholders if they seek to approve a deal. For investors tracking the redemption mechanics, this sets the initial terms.

This is a new SPAC IPO from a sponsor with a successful track record (Legato I, II, III completed de-SPACs). The trust size of $200M provides significant firepower for a business combination. The filing includes standard terms for a 2025-2026 vintage SPAC, with a 24-month (27-month with LOI) deadline. Investors should review the sponsor's historical performance, potential conflicts, and dilution (founder shares at $0.003). The filing also confirms the trust per-share value of $10.00 (not $10.10 as previously noted in the user's SPAC status, likely due to rounding or interest assumptions).

This filing provides the first detailed disclosure of the SPAC's terms, management team (with track record of eight prior closed SPAC deals), and intended sector focus. It establishes the trust value ($10.00 per share), redemption mechanics (shareholders may redeem at $10.00 per share upon a business combination or if the deadline is extended), and potential dilution from founder shares and warrants. Investors can now evaluate the offering structure and sponsor incentives.

What changed: A routine Form 4 insider ownership report documenting a post-trade securities disclosure for Legato Merger Corp. IV. The filing discloses that on July 27, 2026, director Brian Pratt sold 40,000 shares via an open-market transaction at $0.003 per share. The report states Pratt retains 1,160,000 shares following the disposition. The document lists no amendments to prior holdings, no block trades, and no affiliated company transactions. Why it matters: As a mandatory Section 16(a) filing, the document triggers no changes to the SPAC’s redemption schedule, trust account administration, extension voting mechanics, or business combination deadline. The $0.003 execution price cited in the Form 4 reflects secondary market trading well below standard trust redemption floors, indicating market liquidity or pricing conditions rather than sponsor-level capital decisions. The filing contains no statements from executive officers, sponsors, or independent directors regarding target evaluation, customer relationships, revenue streams, market positioning, technology development, strategic partnerships, or active litigation. Director Pratt’s disclosed equity reduction is purely transactional and does not signal deal progress, trust withdrawals, or changes to sponsor alignment.

What changed: Quarterly report on Form 10-Q filed by Legato Merger Corp. IV (blank check company) for the quarter ended May 31, 2026, containing unaudited financial statements and management discussion. No deal announcement, extension, or sponsor conduct change. The trust account per-share redemption value increased from $10.00 to $10.10 due to interest earned; cash held outside trust is $2,427,888. No new redemption deadlines or revisions to the business combination period (24 months from closing of IPO, or 27 months if a letter of intent, etc., is signed). Why it matters: Provides investors with updated trust value and confirms the search timeline. The increase in per-share redemption value (to $10.10) and the absence of any operational changes are relevant for shareholders evaluating redemption or holding decisions.

What changed: Joint Acquisition Statement signature page filed under SEC Rule 13d-1(k), formally establishing that Adage Capital Management, L.P., Robert Atchinson, and Phillip Gross are filing the attached Schedule 13G collectively. The document records a joint-acquisition agreement among the three holders, stipulating that each signer accepts individual responsibility for the timeliness and accuracy of their own disclosed information while declining liability for the others’ data unless they possess knowledge of its inaccuracy. This exhibit contains no share quantities, acquisition prices, dates, or explicit references to the SPAC’s redemption calendar, trust balance, or business combination search. Why it matters: Investors monitoring the January 23, 2028 deadline and potential redemptions must recognize that this filing coordinates regulatory reporting for the underlying stakeholder group. Because the attached page is purely procedural, the substantive metrics needed to assess voting weight at upcoming shareholder meetings—aggregate shares beneficially owned, percentage of outstanding public shares, acquisition date, and source of funds—are absent here and must be located on the preceding items of the full Schedule 13G. Until those items are reviewed, the exact influence of Adage Capital Management and the two individuals on any future extension vote or business combination approval remains unquantified in this text.

What changed: 10-Q quarterly report for the quarter ended February 28, 2026, filed April 14, 2026. This is the first quarterly report since the IPO closed on January 26, 2026, providing financial statements, trust account details, and business combination status. No changes to trust mechanics, redemption terms, or business combination deadline since IPO. Trust value per public share is $10.03 as of Feb 28, 2026 (up from $10.00 due to interest income). No business combination announced or letter of intent disclosed. No extension votes, amendments, or new sponsor conduct issues. Related party transactions unchanged from IPO. No insider trading arrangements adopted or terminated during the quarter. Why it matters: For investors monitoring trust value and deadlines: trust per share is $10.03. The deadline for a business combination is 24 months from IPO closing (Jan 26, 2026 -> Jan 26, 2028) or 27 months if a definitive agreement is signed within 24 months. No target has been identified; the SPAC remains in searching phase. Expenses are minimal (G&A $90k for six months). This filing establishes baseline financials for tracking future trust erosion, expenses, and deal progress.

What changed: A Form 4 — insider ownership report [0001094891-26-000100] filed by Eric Rosenfeld, identified as Chief SPAC Officer of Legato Merger Corp. IV. The filing discloses that, on 2026-03-05, Eric Rosenfeld conducted an open-market purchase of 1,440,000 shares at $0.003, resulting in a post-transaction holding of 1,440,000 shares. Per the report, the document contains no substantive assertions regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel adjustments beyond the officer’s corporate title. Why it matters: The Form 4 provides a direct record of a sponsor-affiliated officer deploying capital into the public market at $0.003, which tracks sponsor conduct and insider positioning. According to the filing, this open-market acquisition does not alter the SPAC’s SEARCHING status, the stated $10.1 trust per share, or the 2028-01-23 deadline. Because the transaction was executed on the open market rather than through the trust account or underwriting syndicate, neither the redemption calendar, trust distribution mechanics, nor any potential extension timeline are affected by this submission.

What changed: Form 4 — insider ownership report. This is a Form 4 — insider ownership report. According to the submitted filing, Eric Rosenfeld (Chief SPAC Officer) executed an open-market sale on 2026-03-04, disposing of 1,440,000 shares at $0.003 per share, and reports holding 1,348,217 shares afterward. This entry records sponsor conduct and insider liquidity activity. It does not amend the registered redemption deadline of 2028-01-23, touch any trust account mechanics, advance the status toward a business combination, or request an extension of the search period. The text contains no assertions regarding customers, revenue, market size, strategy, technology, partnerships, active litigation, or personnel changes. Why it matters: Investors tracking redemption windows and sponsor behavior should note that the executive’s reported sale of 1,440,000 shares at $0.003 reveals a heavily discounted secondary market environment while the entity remains in SEARCHING status. The filing explicitly states the executive retains 1,348,217 shares post-transaction, indicating partial rather than complete capital exit. Because the Form 4 was self-filed by the Chief SPAC Officer, the volume and price figures are administered facts rather than guidance. Without disclosed merger targets or timeline modifications, this submission functions primarily as a liquidity checkpoint. Market participants monitoring for extension votes or deSPAC accelerations should watch subsequent quarterly filings to see whether this partial divestment precedes a negotiated timeline change or a targeted acquisition announcement.

What changed: Quarterly Report (Form 10-Q) for Legato Merger Corp. IV, a newly-formed blank check SPAC, covering its first fiscal quarter from inception (September 1, 2025) through November 30, 2025. The filing reports the company's pre-IPO formation activities and, through a subsequent event note, confirms its IPO closed on January 26, 2026. This is the company's first quarterly report. The period ended November 30, 2025 predates the IPO. The only subsequent event (Note 9) reports the January 26, 2026 consummation of the IPO (23,000,000 units for $230 million gross), full exercise of the over-allotment (3,000,000 units), and a concurrent private placement (550,000 units for $5.5 million). Pre-IPO, the company had $85 in cash, $57,950 in deferred offering costs, and a working capital deficit of $79,156. Trust value is not established until the post-balance-sheet IPO. The company remains in pre-business-combination search status. Why it matters: For an investor tracking SPAC mechanics, this filing confirms the SPAC is now funded. As stated by the company, the trust holds $230,000,000 ($10.00 per public share, which matches the trust/share benchmark). The 24-month deadline for a business combination runs from January 26, 2026, extendable to 27 months if a definitive agreement is signed within 24 months. The filing also confirms the sponsor's 25% founder stake (7,666,667 shares after full exercise of the over-allotment) and that warrants are classified as equity. The document includes management compensation details ($5,000/month to CEO/CFO) and an administrative fee ($25,000/month to an affiliate of the sponsor). No target or letter of intent has been announced.

What changed: This document IS a Schedule 13D beneficial ownership report, classified in its own terms as a statutory disclosure exhibit required when a person or group acquires more than the statutory threshold of voting securities in a registrant. The provided excerpt consists solely of the filing title and a system indexer noting that a structured holder table is absent from this XML variant. The filing text does not adjust redemption calendar parameters, trust share valuations, extension mechanisms, target acquisition milestones, or sponsor governance conduct. Mechanically, this report establishes a public registry of a concentrated equity accumulation, which can trigger amendment obligations under Securities Exchange Act rules and alter voting weight distributions for upcoming shareholder actions. Why it matters: Investors tracking redemption windows, trust capital maintenance, and merger execution should view this report as a structural inflection point in shareholder composition. Concentrated blockholder entry frequently shifts sponsor negotiation leverage, influences redemption susceptibility through coordinated public statements, and may precede proposals that extend timelines or restructure the capital stack. The document contains no direct commentary on target customer relationships, revenue streams, market positioning, technological capabilities, partnership frameworks, personnel transitions, or ongoing litigation; any substantive operational claims would require examination of subsequent Schedule 13G/A amendments, accompanying press releases, or proxy solicitations.

What changed: This filing IS an SEC Form 3 initial beneficial ownership report classifying Legato Merger Corp. IV as the issuer and Ing John as a director, recording an indirect stake of 180,000 shares. On redemption deadlines, trust value, extensions, deal progress, and sponsor conduct, the submission registers no updates; it does not propose an amendment, trigger a vote, alter the trust account, or advance a target search. According to the Form 3 text itself, Director Ing John holds 180,000 shares indirectly, with no acquisition date, purchase price, or disposition logged. Why it matters: Beyond the mechanical calendar and trust parameters, the document confirms pre-business-combination insider equity placement. The report attributes the 180,000 indirect shares to Director Ing John but supplies neither funding source nor transaction timing, meaning it reflects administrative compliance rather than a strategic signal about sponsor alignment or upcoming redemption overhang. Investors tracking these mechanics should treat the filing as a baseline ownership anchor until subsequent forms disclose actual purchases, sales, or warrant conversions that would impact share supply ahead of a merger vote.

What changed: A Form 8-K filing reporting the closing of an Initial Public Offering and a concurrent private placement, accompanied by audited financial statements and a corporate press release. According to the filing’s Item 8.01 and Exhibit 99.2, Legato Merger Corp. IV closed its IPO on January 26, 2026, selling 23,000,000 Units at $10.00 per Unit for $230,000,000 in gross proceeds, after fully exercising a 3,000,000-unit underwriters’ over-allotment option on January 23, 2026. The Company simultaneously sold 550,000 Private Placement Units for $5,500,000. Per Note 1 of the financial statements, $230,000,000 was deposited into a Trust Account, creating an initial per-share value of $10.00 for the 23,000,000 Public Shares. The filing establishes a 24-month Combination Period from the closing date, which automatically extends to 27 months if the Company executes a letter of intent, agreement in principle, or definitive agreement for an initial Business Combination within the first 24 months. The Company had not yet commenced operations prior to this event. Why it matters: This filing codifies the structural and financial parameters governing future redemptions, extensions, and sponsor incentives. Per Note 1 and Note 5, Insiders (officers, directors, and initial shareholders) waived redemption rights for Founder and Private Shares but will participate in liquidating distributions from the Trust Account only if the Company fails to complete a Business Combination within the Combination Period, at which point the per-share residual value may drop below the $10.00 Public Share offering price. Management, led by CEO Gregory Monahan, intends to initially target businesses in infrastructure, industrial, artificial intelligence, and technology, though NYSE listing rules mandate a target fair market value equal to at least 80% of the Trust Account balance at execution. Cost structures are fixed: $25,000 monthly administrative fees to Crescendo Advisors II, LLC, and BTIG, LLC receiving a $3,450,000 upfront underwriting discount plus deferred commissions capped at $8,050,000. Critically, while Crescendo Advisors LLC (affiliated with Chief SPAC Officer Eric Rosenfeld) agreed to indemnify the Trust Account to prevent balances from falling below $10.00 per share against third-party vendor claims, the Company explicitly states it has neither verified Crescendo Advisors’ liquidity nor requested it to reserve funds for those obligations. Warrants carry a $11.50 exercise price and expire five years post-combination.